0B68 McKenzie, Steven E. - Thomas Jefferson University < 6208 div id="global-header" class="global-header">
Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

McKenzie, Steven E.

< Back

Profile

file

Steven E. McKenzie, MD, PhD

Contact Dr. McKenzie

1020 Locust Street
Suite 394
Philadelphia, PA 19107

(215) 955-3900
(215) 923-3836 fax

Research & Clinical Interests

Dr. McKenzie directs two major research projects. The first project involves vascular biology, with a focus on immune-mediated thrombocytopenia and thrombosis syndromes. This work, done in collaboration with Dr. Michael Reilly, led to the first model of heparin-induced thrombocytopenia and thrombosis. New work on effects of elevated cholesterol and athrosclerosis on HITT, and on microparticles and tissue factor, is ongoing.

Publications

Most Recent Peer-Reviewed Publications

  1. Syk inhibition in ischemic stroke
  2. Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice
  3. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs
  4. Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation
  5. MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression
  6. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics
  7. The human platelet: Strong transcriptome correlations among individuals associate weakly with the platelet proteome
  8. Identification of a developmental gene expression signature, including hox genes, for the normal human colonic crypt stem cell niche: Overexpression of the signature parallels stem cell overpopulation during colon tumorigenesis
  9. Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia
  10. CalDAG-GEFI deficiency protects mice from FcγRIIa-mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes
  11. Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms
  12. MicroRNAs in platelet production and activation
  13. Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo
  14. The complex transcriptional landscape of the anucleate human platelet
  15. Monocytes in HIT: An evolving story
  16. CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia
  17. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
  18. PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
  19. Amelioration of murine immune thrombocytopenia by CD44 antibodies: A potential therapy for ITP?
  20. Dominant expression of the inhibitory FcγRIIB prevents antigen presentation by murine plasmacytoid dendritic cells
0